A thalamocorticostriatal dopamine network for psychostimulant-enhanced human cognitive flexibility

Biological Psychiatry

Volumn 74, Issue 2, 2013, Pages 99-105

  Samanez Larkin, Gregory R ^a   Buckholtz, Joshua W ^b   Cowan, Ronald L ^a   Woodward, Neil D ^a   Li, Rui ^a   Ansari, M Sib ^a   Arrington, Catherine M ^c   Baldwin, Ronald M ^d   Smith, Clarence E ^e   Treadway, Michael T ^f   Kessler, Robert M ^a   Zald, David H ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b HARVARD UNIVERSITY   (United States)

^c LEHIGH UNIVERSITY   (United States)

^d Molecular Neuroimaging   (United States)

^e DXP Imaging   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Amphetamine; cognitive control; dopamine; flexibility; parietal cortex; PET; prefrontal cortex; striatum; thalamus

Indexed keywords

AMPHETAMINE; BRAIN RECEPTOR; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; FALLYPRIDE F 18; FLUORINE 18; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; COGNITION; COGNITIVE FLEXIBILITY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NERVE CELL NETWORK; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STRIATE CORTEX; TASK PERFORMANCE; TASK POSITIVE NETWORK; THALAMOCORTICAL TRACT; THALAMOCORTICOSTRIATAL NETWORK;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; BENZAMIDES; CEREBRAL CORTEX; COGNITION; CORPUS STRIATUM; DEXTROAMPHETAMINE; DOPAMINE; DOPAMINE ANTAGONISTS; FEMALE; HUMANS; MALE; NERVE NET; PYRROLIDINES; THALAMUS; YOUNG ADULT;

EID: 84879487970     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2012.10.032     Document Type: Article

References (55)

1. D.Y. Kimberg, G.K. Aguirre, and M. D'Esposito Modulation of task-related neural activity in task-switching: An fMRI study Brain Res Cogn Brain Res 10 2000 189 196
2. M.H. Sohn, S. Ursu, J.R. Anderson, V.A. Stenger, and C.S. Carter The role of prefrontal cortex and posterior parietal cortex in task switching PNAS 97 2000 13448 13453
3. A.R. Aron, S. Monsell, B.J. Sahakian, and T.W. Robbins A componential analysis of task-switching deficits associated with lesions of left and right frontal cortex Brain 127 2004 1561 1573
4. R. Cools, R.B. Ivry, and M. D'Esposito The human striatum is necessary for responding to changes in stimulus relevance J Cogn Neurosci 18 2006 1973 1983
5. D. Badre, and A.D. Wagner Computational and neurobiological mechanisms underlying cognitive flexibility PNAS 103 2006 7186 7191
6. M. Esterman, Y.-C. Chiu, B.J. Tamber-Rosenau, and S. Yantis Decoding cognitive control in human parietal cortex PNAS 106 2009 17974 17979
7. B.T. Gold, D.K. Powell, L. Xuan, G.A. Jicha, and C.D. Smith Age-related slowing of task switching is associated with decreased integrity of frontoparietal white matter Neurobiol Aging 31 2010 512 522
8. C. Kim, N.F. Johnson, S.E. Cilles, and B.T. Gold Common and distinct mechanisms of cognitive flexibility in prefrontal cortex J Neurosci 31 2011 4771 4779
9. T.W. Robbins Shifting and stopping: Fronto-striatal substrates, neurochemical modulation and clinical implications Philos Trans R Soc Lond B Biol Sci 362 2007 917 932
10. A.A. Kehagia, G.K. Murray, and T.W. Robbins Learning and cognitive flexibility: Frontostriatal function and monoaminergic modulation Curr Opin Neurobiol 20 2010 199 204
11. S. Monsell Task switching Trends Cogn Sci 7 2003 134 140
12. A.F. Kramer, N.J. Cepeda, and M.L. Cepeda Methylphenidate effects on task-switching performance in attention-deficit/hyperactivity disorder J Am Acad Child Adolesc Psychiatry 40 2001 1277 1284
13. R. Cools, R.A. Barker, B.J. Sahakian, and T.W. Robbins L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease Neuropsychologia 41 2003 1431 1441
14. C. Wasylyshyn, P. Verhaeghen, and M.J. Sliwinski Aging and task switching: A meta-analysis Psychol Aging 26 2011 15 20
15. R.D. Oades The role of noradrenaline in tuning and dopamine in switching between signals in the CNS Neurosci Biobehav Rev 9 1985 261 282
16. J.L. Evenden, and T.W. Robbins The effects of d-amphetamine, chlordiazepoxide and alpha-flupenthixol on food-reinforced tracking of a visual stimulus by rats Psychopharmacology 85 1985 361 366
17. H.S. Crofts, J.W. Dalley, P. Collins, J.C. Van Denderen, B.J. Everitt, and T.W. Robbins Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set Cereb Cortex 11 2001 1015 1026
18. M.A. Mehta, F.F. Manes, G. Magnolfi, B.J. Sahakian, and T.W. Robbins Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers Psychopharmacology 176 2004 331 342
19. S.E. McCabe, J.R. Knight, C.J. Teter, and H. Wechsler Non-medical use of prescription stimulants among US college students: Prevalence and correlates from a national survey Addiction 100 2005 96 106
20. M. van Holstein, E. Aarts, M.E. van der Schaaf, D.E.M. Geurts, R.J. Verkes, and B. Franke Human cognitive flexibility depends on dopamine D2 receptor signaling Psychopharmacology 218 2011 567 578
21. L.S. Colzato, F. Waszak, S. Nieuwenhuis, D. Posthuma, and B. Hommel The flexible mind is associated with the catechol-O-methyltransferase (COMT) Val158Met polymorphism: Evidence for a role of dopamine in the control of task-switching Neuropsychologia 48 2010 2764 2768
22. C. Stelzel, U. Basten, C. Montag, M. Reuter, and C.J. Fiebach Frontostriatal involvement in task switching depends on genetic differences in d2 receptor density J Neurosci 30 2010 14205 14212
23. E. Aarts, A. Roelofs, B. Franke, M. Rijpkema, G. Fernández, and R.C. Helmich Striatal dopamine mediates the interface between motivational and cognitive control in humans: Evidence from genetic imaging Neuropsychopharmacology 35 2010 1943 1951
24. R. Rogers, and S. Monsell Costs of a predictable switch between simple cognitive tasks J Exp Psychol Gen 124 1995 207 231
25. P. Riccardi, R. Li, M.S. Ansari, D. Zald, S. Park, and B. Dawant Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans Neuropsychopharmacology 31 2006 1016 1026
26. D.H. Zald, N.D. Woodward, R.L. Cowan, P. Riccardi, M.S. Ansari, and R.M. Baldwin The interrelationship of dopamine D2-like receptor availability in striatal and extrastriatal brain regions in healthy humans: A principal component analysis of [18F]fallypride binding Neuroimage 51 2010 53 62
27. B.T. Christian, T. Narayanan, B. Shi, E.D. Morris, J. Mantil, and J. Mukherjee Measuring the in vivo binding parameters of [18F]-fallypride in monkeys using a PET multiple-injection protocol J Cereb Blood Flow Metab 24 2004 309 322
28. J.W. Buckholtz, M.T. Treadway, R.L. Cowan, N.D. Woodward, R. Li, and M.S. Ansari Dopaminergic network differences in human impulsivity Science 329 2010 532
29. J.W. Buckholtz, M.T. Treadway, R.L. Cowan, N.D. Woodward, S.D. Benning, and R. Li Mesolimbic dopamine reward system hypersensitivity in individuals with psychopathic traits Nat Neurosci 13 2010 419 421
30. Kessler RM (1995): Imaging of Cerebral Dopamine D2 Receptors; IND application 47,245.
31. A.A. Lammertsma, C.J. Bench, S.P. Hume, S. Osman, K. Gunn, and D.J. Brooks Comparison of methods for analysis of clinical [11C]raclopride studies J Cereb Blood Flow Metab 16 1996 42 52
32. H. Hall, G. Sedvall, O. Magnusson, J. Kopp, C. Halldin, and L. Farde Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain Neuropsychopharmacology 11 1994 245 256
33. 18F]N-allyl-5-fluoropropylepidepride (fallypride): Radiation dosimetry, quantification of striatal and extrastriatal dopamine receptors in man Neuroimage 11 2000 S32
34. J.K. Seamans, and C.R. Yang The principal features and mechanisms of dopamine modulation in the prefrontal cortex Prog Neurobiol 74 2004 1 58
35. M. Wang, S. Vijayraghavan, and P.S. Goldman-Rakic Selective D2 receptor actions on the functional circuitry of working memory Science 303 2004 853 856
36. R. Cools, and M. D'Esposito Inverted-U-shaped dopamine actions on human working memory and cognitive control Biol Psychiatry 69 2011 e113 e125
37. V.S. Mattay, T.E. Goldberg, F. Fera, A.R. Hariri, A. Tessitore, and M.F. Egan Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine PNAS 100 2003 6186 6191
38. R. Cools Dopaminergic control of the striatum for high-level cognition Curr Opin Neurobiol 21 2011 402 407
39. M.R. van Schouwenburg, H.E.M. Ouden den, and R. Cools The human basal ganglia modulate frontal-posterior connectivity during attention shifting J Neurosci 30 2010 9910 9918
40. F. McNab, and T. Klingberg Prefrontal cortex and basal ganglia control access to working memory Nat Neurosci 11 2008 103 107
41. C.W. Berridge, and T.A. Stalnaker Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex Synapse 46 2002 140 149
42. P.L. Clatworthy, S.J.G. Lewis, L. Brichard, Y.T. Hong, D. Izquierdo, and L. Clark Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory J Neurosci 29 2009 4690 4696
43. R. Cools, M.J. Frank, S.E. Gibbs, A. Miyakawa, W.J. Jagust, and M. D'Esposito Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration J Neurosci 29 2009 1538 1543
44. S.N. Haber The primate basal ganglia: Parallel and integrative networks J Chem Neuroanat 26 2003 317 330
45. G.E. Alexander, M.D. Crutcher, and M.R. DeLong Basal ganglia- thalamocortical circuits: Parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions Prog Brain Res 85 1990 119 146
46. J.W. Mink The basal ganglia: Focused selection and inhibition of competing motor programs Prog Neurobiol 50 1996 381 425
47. M.A. Sánchez-González, M.A. García-Cabezas, B. Rico, and C. Cavada The primate thalamus is a key target for brain dopamine J Neurosci 25 2005 6076 6083
48. M.A. García-Cabezas, P. Martínez-Sánchez, M.A. Sánchez-González, M. Garzón, and C. Cavada Dopamine innervation in the thalamus: Monkey versus rat Cereb Cortex 19 2009 424 434
49. C. Advokat What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD) Neurosci Biobehav Rev 34 2010 1256 1266
50. D.F. Hermens, N.J. Cooper, M. Kohn, S. Clarke, and E. Gordon Predicting stimulant medication response in ADHD: Evidence from an integrated profile of neuropsychological, psychophysiological and clinical factors J Integr Neurosci 4 2005 107 121
51. R.E. Featherstone, Z. Rizos, S. Kapur, and P.J. Fletcher A sensitizing regimen of amphetamine that disrupts attentional set-shifting does not disrupt working or long-term memory Behav Brain Res 189 2008 170 179
52. J.M. Swanson, and N.D. Volkow Increasing use of stimulants warns of potential abuse Nature 453 2008 586
53. H. Greely, B. Sahakian, J. Harris, R.C. Kessler, M. Gazzaniga, and P. Campbell Towards responsible use of cognitive-enhancing drugs by the healthy Nature 456 2008 702 705
54. B. Maher Poll results: Look who's doping Nature 452 2008 647 675
55. N.M. Lambert, M. McLeod, and S. Schenk Subjective responses to initial experience with cocaine: An exploration of the incentive-sensitization theory of drug abuse Addiction 101 2006 713 725